Competitors of Glenmark Pharmaceuticals Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,465 Cr. | 318 | 390/108 | 65.7 | 20.5 | 0.21 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 59.8 Cr. | 80.6 | 94.9/25.8 | 22.9 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 28.0 Cr. | 19.1 | 19.5/8.35 | 36.3 | 6.64 | 0.00 % | 4.06 % | 3.33 % | 10.0 |
| Godavari Drugs Ltd | 85.5 Cr. | 114 | 155/87.0 | 12.8 | 55.4 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 13,221 Cr. | 1,080 | 1,335/620 | 31.2 | 207 | 2.08 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 431 Cr. | 19.0 | 29.0/13.2 | 24.9 | 7.68 | 0.00 % | 14.4 % | 10.4 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.25 Cr. | 15.0 | 28.5/13.1 | 145 | 13.4 | 0.00 % | 3.19 % | 0.84 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 316 Cr. | 672 | 1,054/650 | 17.9 | 278 | 0.10 % | 17.6 % | 15.0 % | 10.0 |
| Fervent Synergies Ltd | 47.0 Cr. | 15.7 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 962 Cr. | 327 | 355/145 | 117 | 98.6 | 0.38 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 5.88 Cr. | 28.0 | 43.8/23.6 | 118 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 18.2 Cr. | 7.31 | 19.4/7.21 | 40.5 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 116 Cr. | 145 | 184/110 | 50.6 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 107 Cr. | 1.54 | 3.10/0.98 | 145 | 3.80 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 16.2 Cr. | 6.75 | 14.5/6.40 | 14.9 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.4 Cr. | 15.2 | 25.8/14.4 | 18.5 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 273 Cr. | 764 | 999/345 | 11.7 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 35.7 Cr. | 35.7 | 61.5/30.6 | 33.9 | 0.00 % | 4.50 % | 1.29 % | 10.0 | |
| Colinz Laboratories Ltd | 24.0 Cr. | 52.5 | 84.4/36.0 | 43.6 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 12.0 Cr. | 4.81 | 26.5/4.12 | 48.1 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 12.2 Cr. | 81.0 | 94.7/40.4 | 9.72 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.25 Cr. | 13.3 | 17.4/4.09 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 52.1 Cr. | 69.0 | 160/63.0 | 33.0 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.31 Cr. | 21.0 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 99.6 Cr. | 23.1 | 43.9/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 16.4 Cr. | 32.3 | 46.0/19.5 | 48.2 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 177 Cr. | 308 | 408/175 | 18.2 | 110 | 1.46 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 26.1 Cr. | 44.3 | 50.0/4.68 | 66.9 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 71,611 Cr. | 1,220 | 1,593/958 | 19.6 | 527 | 0.37 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 122 Cr. | 195 | 307/112 | 19.8 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 949 Cr. | 189 | 265/140 | 16.1 | 60.5 | 1.32 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 59.4 Cr. | 45.5 | 86.1/43.5 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 8,594 Cr. | 2,098 | 2,185/1,004 | 92.0 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 6.08 Cr. | 0.92 | 1.20/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 417 Cr. | 54.4 | 77.7/37.5 | 31.3 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 14.6 Cr. | 25.0 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 113 Cr. | 67.0 | 82.5/40.2 | 171 | 18.5 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 57,683 Cr. | 27,115 | 30,521/21,983 | 44.9 | 1,657 | 1.51 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,596 Cr. | 617 | 722/381 | 24.5 | 205 | 0.49 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 150 Cr. | 54.7 | 75.8/37.0 | 21.7 | 46.6 | 0.00 % | 6.18 % | 3.81 % | 10.0 |
| Zota Health Care Ltd | 1,501 Cr. | 548 | 725/400 | 58.0 | 0.18 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 19,062 Cr. | 1,175 | 1,335/323 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 707 Cr. | 213 | 291/96.6 | 25.6 | 11.8 | 0.00 % | 62.5 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 11.0 % | 268 % | 2.00 | |
| Venus Remedies Ltd | 398 Cr. | 299 | 430/280 | 18.0 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 6,057 Cr. | 861 | 950/401 | 121 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,032 Cr. | 1,448 | 1,923/1,232 | 31.4 | 735 | 0.69 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,04,981 Cr. | 3,102 | 3,591/2,025 | 60.3 | 222 | 0.90 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,646 Cr. | 288 | 317/154 | 50.0 | 44.8 | 0.17 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,863 Cr. | 19.8 | 27.9/10.5 | 58.6 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 32,444 Cr. | 1,274 | 1,359/585 | 134 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,579 Cr. | 118 | 169/74.5 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,27,575 Cr. | 1,780 | 1,960/1,184 | 38.2 | 288 | 0.76 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,308 Cr. | 761 | 851/292 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,022 Cr. | 239 | 398/113 | 34.4 | 70.6 | 0.17 % | 11.4 % | 9.53 % | 1.00 |
| SMS Lifesciences India Ltd | 307 Cr. | 1,044 | 1,750/487 | 15.1 | 621 | 0.14 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 9,156 Cr. | 936 | 960/313 | 159 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,803 Cr. | 193 | 241/91.8 | 226 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 13,993 Cr. | 6,077 | 7,600/4,606 | 33.2 | 298 | 2.75 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,366 Cr. | 2,032 | 2,977/1,290 | 38.6 | 229 | 0.79 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,512 Cr. | 5,120 | 5,836/4,637 | 37.6 | 324 | 1.17 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 261 Cr. | 73.9 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 23,447 Cr. | 5,131 | 6,453/3,950 | 38.3 | 820 | 0.68 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 346 Cr. | 281 | 325/190 | 19.0 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,527 Cr. | 414 | 415/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 7,478 Cr. | 1,478 | 1,592/557 | 62.8 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 18,979 Cr. | 14,768 | 16,561/4,926 | 71.9 | 1,087 | 0.09 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 771 Cr. | 34.3 | 56.5/26.2 | 71.8 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,596 Cr. | 1,375 | 1,639/752 | 12.6 | 399 | 0.69 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,016 Cr. | 73.2 | 101/38.6 | 30.6 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,987 Cr. | 309 | 329/126 | 40.4 | 50.3 | 0.19 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 165 Cr. | 104 | 145/85.2 | 17.5 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 506 Cr. | 142 | 173/97.9 | 160 | 27.7 | 0.00 % | 3.95 % | 6.61 % | 10.0 |
| Lupin Ltd | 93,253 Cr. | 2,043 | 2,312/1,184 | 35.5 | 343 | 0.39 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,238 Cr. | 617 | 814/498 | 12.8 | 319 | 0.29 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 26,365 Cr. | 489 | 518/359 | 112 | 79.2 | 0.16 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 905 Cr. | 872 | 961/356 | 26.3 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 177 Cr. | 82.3 | 122/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 965 Cr. | 200 | 370/198 | 18.2 | 103 | 1.50 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 496 Cr. | 306 | 470/298 | 35.3 | 118 | 0.00 % | 12.8 % | 7.83 % | 10.0 |
| Jubilant Pharmova Ltd | 17,997 Cr. | 1,130 | 1,310/409 | 63.2 | 373 | 0.44 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,454 Cr. | 1,702 | 2,030/1,371 | 43.3 | 207 | 0.72 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,565 Cr. | 593 | 635/270 | 58.5 | 74.4 | 0.84 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 39,957 Cr. | 1,574 | 1,709/1,041 | 64.1 | 264 | 0.25 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,008 Cr. | 342 | 538/331 | 20.0 | 283 | 1.46 % | 12.3 % | 8.68 % | 10.0 |
| Indoco Remedies Ltd | 2,764 Cr. | 300 | 417/286 | 124 | 118 | 0.50 % | 10.4 % | 8.33 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 41,388 Cr. | 1,466 | 1,831/761 | 299 | 0.17 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 40,172 Cr. | 2,370 | 3,088/1,616 | 50.1 | 98.7 | 1.35 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 99,697 Cr. | 1,195 | 1,421/1,074 | 18.7 | 369 | 0.67 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,418 Cr. | 219 | 283/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,18,369 Cr. | 1,466 | 1,702/1,165 | 25.7 | 351 | 0.89 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,774 Cr. | 1,943 | 2,177/1,178 | 30.0 | 334 | 0.26 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 363 Cr. | 139 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,358 Cr. | 129 | 150/92.2 | 15.4 | 96.0 | 0.39 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 95.8 Cr. | 59.0 | 92.0/42.6 | 181 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 38,785 Cr. | 323 | 396/231 | 26.9 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,906 Cr. | 1,983 | 2,326/1,060 | 46.5 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 214 Cr. | 134 | 158/89.0 | 28.1 | 43.2 | 0.89 % | 12.1 % | 11.1 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 188 Cr. | 79.3 | 113/73.2 | 244 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 15,762 Cr. | 6,305 | 8,140/4,050 | 122 | 272 | 0.38 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,048 Cr. | 706 | 863/556 | 43.1 | 103 | 0.65 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 226 Cr. | 111 | 145/69.9 | 10.9 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 67,068 Cr. | 5,605 | 6,440/4,407 | 30.9 | 961 | 0.71 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,356 Cr. | 1,038 | 1,304/710 | 32.0 | 249 | 1.06 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 722 Cr. | 1,275 | 1,754/911 | 10.5 | 724 | 0.90 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 36,722 Cr. | 2,946 | 3,486/1,850 | 42.0 | 294 | 1.22 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 4,147 Cr. | 371 | 571/321 | 28.3 | 120 | 1.38 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,183 Cr. | 455 | 635/430 | 33.4 | 126 | 0.22 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,460.76 Cr | 1,177.05 | 54.20 | 184.88 | 0.33% | 16.40% | 16.92% | 6.61 |
